ERBB2 and breast carcinoma: In the same study that loaded HChrR6 mRNA, Wang et al. further transfected HEK293FT cells with a synthetic construct (pEVC1C2HER), enabling the isolated EVs to target HER2-positive breast cancer cells [93].